A trial of 3,127 patients who took a daily pill for 72 weeks saw an average weight loss per person of 12.3kg. While injectable obesity drugs are peptides designed to replicate the appetite-controlling ...

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

A weight loss pill called orforglipron has had some successful results from the human trial stage, so when could we see it on the NHS?

By Twesha Dikshit (Reuters) -European stocks edged higher on Friday, led by upbeat corporate earnings and a jump in Novo Nordisk shares, and were set for their biggest weekly gain in twelve. Novo ...